(bevacizumab), classified as an angiogenesis inhibitor, is a drug that slows the growth of new blood cells.  Manufactured by the San Francisco-based company Genentech, a subsidiary of Roche Pharmaceuticals, Avastin was first approved in 2004 for certain types of cancers of the , lung, colon, rectum, and brain that are metastatic, or have spread to other parts of the body. Working in conjunction with chemotherapy or alone, Avastin, given intravenously, interferes with the growth and spread of cancer cells.

While indicated for many types of cancer treatments, some medical providers prescribe it off-label, or for treatments not approved by the U. S. Food and Drug Administration (FDA).

Previous ArticleAvastin's Many Black Box Warnings Next ArticleAvastin's Legal Woes
Verdicts and Settlements
Newsletter
Contact Us

Subscribe Now!

[contact-form-7 404 "Not Found"]

Follow Us!

Unsafe Drugs has numerous resources on drug side effects,nutritional supplements, vitamins, and health products.

Site best viewed in Google Chrome, Firefox, Opera, Safari, IE browsers